Whalegun
List

Accelerating Medical Treatments for Serious Mental Illness

Executive orderRegulation easedSigned 04/18Federal Register 04/22Executive Order 14401Open the original

Summary

President Trump signs an executive order on serious mental illness, noting that psychedelic drugs such as ibogaine compounds show potential in clinical studies for patients who do not respond to standard therapy, and making it policy to accelerate research and appropriate drug approvals to widen access.

By industry

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
DayHealthcare & Drug Pricing stocksS&P 500
26/04/170.0%0.0%
26/04/20−1.1%−0.1%
26/04/21−1.7%−0.5%
26/04/22−2.2%+0.0%
26/04/23−0.9%−0.1%
26/04/24−2.1%+0.5%
26/04/27−2.2%+0.8%
26/04/28−1.3%+0.3%
26/04/29−0.7%+0.4%
26/04/30+0.3%+1.4%
26/05/01−0.7%+1.3%
26/05/04−0.8%+1.1%
26/05/05−1.0%+2.3%
26/05/06−1.8%+3.2%
26/05/07−2.1%+2.9%
26/05/08−2.2%+3.9%
26/05/11−1.8%+4.1%
26/05/12+0.1%+3.8%
26/05/13+1.0%+4.7%
26/05/14+1.1%+5.3%
26/05/15−0.2%+3.9%

Korean stocks in these industries

  • Samsung Biologics 207940
  • Celltrion 068270
  • SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

  • Alan Armstrong

    BuyUnitedhealth Group

    $15K–$50K

    Reported 07/21

  • Alan Armstrong

    Full saleAmgen

    $15K–$50K

    Reported 07/21

  • Alan Armstrong

    Full salePfizer

    $50K–$100K

    Reported 07/21

  • Lilly Endowment

    SellELI Lilly

    $13.6M

    Filed 05/07

  • Alan Armstrong

    Full saleMerck

    $15K–$50K

    Reported 07/21

  • Alan Armstrong

    BuyAbbVie

    $15K–$50K

    Reported 07/21

  • Alan Armstrong

    BuyJohnson & Johnson

    $15K–$50K

    Reported 07/21

  • Larry Robbins

    SellCVS Health

    $187.3M

    Filed 05/21

  • Larry Robbins

    SellCVS Health

    $74.6M

    Filed 05/21

  • Larry Robbins

    SellCVS Health

    $34.6M

    Filed 05/21

  • Alan Armstrong

    BuyElevance Health

    $1K–$15K

    Reported 07/21

  • Alan Armstrong

    BuyMcKesson

    $1K–$15K

    Reported 07/21

  • Alan Armstrong

    Full saleELI Lilly

    $1K–$15K

    Reported 07/21

  • Alan Armstrong

    BuyGilead Sciences

    $1K–$15K

    Reported 07/21

  • Alan Armstrong

    BuyJohnson & Johnson

    $1K–$15K

    Reported 07/21

  • Patrick Hugh Conway

    SellUnitedhealth Group

    $284K

    Filed 04/27

  • Lilly Endowment

    SellELI Lilly

    $2.2M

    Filed 05/07

  • David V. Elkins

    SellBristol Myers Squibb

    $1.6M

    Filed 04/02

  • Larry Robbins

    SellCVS Health

    $14.5M

    Filed 05/21

  • Daniel Patrick O'Day

    Sell10b5-1 planGilead Sciences

    $1.4M

    Filed 03/30

Accelerating Medical Treatments for Serious Mental Illness | Whalegun